Related Experiment Video

Updated: May 9, 2026

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

Cancer detection using whole-genome sequencing of cell free DNA

Rebecca J Leary, Mark Sausen, Luis A Diaz

    Oncotarget
    |August 6, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
    11:11

    Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

    Published on: August 24, 2017

    Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
    11:02

    Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

    Published on: October 18, 2013

    Related Experiment Videos

    Last Updated: May 9, 2026

    Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
    08:25

    Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

    Published on: September 9, 2020

    Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
    11:11

    Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

    Published on: August 24, 2017

    Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
    11:02

    Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

    Published on: October 18, 2013

    Related Concept Videos

    Cancers Originate from Somatic Mutations in a Single Cell02:21

    Cancers Originate from Somatic Mutations in a Single Cell

    Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

    Articles linked to this work by shared authors, journal, and citation graph.

    Reference-Free Microsatellite Instability Detection from Tumor Sequencing Using Intrasample Variability Modeling.

    Computational and structural biotechnology journal·2026

    Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Tumor microbial burden drives immune responses through regulation of Interferon signaling.

    Cancer discovery·2026

    Molecular Lineages of Sporadic Mismatch Repair-Deficient Colorectal Cancer.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients.

    European journal of cancer (Oxford, England : 1990)·2026

    Re-expression of MHC-I to treat CNS cancers.

    Oncotarget·2026

    Lactate-induced epithelial-mesenchymal transition: a metabolic nexus in pancreatic cancer metastasis.

    Translational cancer research·2026

    Hypoxia-inducible factor-1α promotes the malignant progression of cervical cancer cells by regulating lactate dehydrogenase A-mediated glycolysis.

    Translational cancer research·2026

    Feasibility, reliability, and clinical value of genomic assay on pre-therapeutic biopsy for endocrine receptor-positive HER2-negative early breast cancer.

    Frontiers in oncology·2026

    Conventional chest CT features are associated with Ki-67 labeling index in lung adenocarcinoma: a single-center retrospective radiopathologic study.

    Journal of thoracic disease·2026

    Epigenetic profiling of circulating cell-free DNA for early detection and minimal residual disease assessment in lung cancer: a focus on DNA methylation.

    Frontiers in oncology·2026

    Diagnosing lung cancer invading the pulmonary artery using ultra-low-dose CT pulmonary angiography: a feasibility study.

    Journal of thoracic disease·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us